Edition:
United Kingdom

Aimmune Therapeutics Inc (AIMT.OQ)

AIMT.OQ on NASDAQ Stock Exchange Global Select Market

34.16USD
11 Dec 2017
Change (% chg)

$-0.00 (-0.00%)
Prev Close
$34.16
Open
$34.47
Day's High
$35.04
Day's Low
$34.08
Volume
162,539
Avg. Vol
139,398
52-wk High
$38.86
52-wk Low
$15.97

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Jun '17 0.00 -0.647
Mar '17 0.00 -0.517
FY 2016 Dec '16 0.00 -0.551
Sep '16 0.00 -0.526
Jun '16 0.00 -0.434
Mar '16 0.00 -0.372
FY 2015 Dec '15 0.00 -0.383
Sep '15 0.00 -0.357
Jun '15 0.00 -0.181
Mar '15 0.00 -0.085
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 5 0.00 0.00 0.00 0.00
Quarter Ending Mar-18 3 0.00 0.00 0.00 --
Year Ending Dec-17 5 0.00 0.00 0.00 0.00
Year Ending Dec-18 5 0.00 0.00 0.00 20.19
Earnings (per share)
Quarter Ending Dec-17 5 -0.71 -0.65 -0.84 -0.51
Quarter Ending Mar-18 4 -0.76 -0.59 -0.89 --
Year Ending Dec-17 5 -2.51 -2.45 -2.63 -2.54
Year Ending Dec-18 5 -3.09 -2.33 -3.56 -2.60
LT Growth Rate (%) 1 34.60 34.60 34.60 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 31.14 32.93
P/E High - Last 5 Yrs. -- 40.91 45.62
P/E Low - Last 5 Yrs. -- 23.80 24.34
Beta -- 0.90 0.88
Price to Sales (TTM) -- 3.93 5.40
Price to Book (MRQ) 5.40 4.81 5.38
Price to Tangible Book (MRQ) 5.41 5.53 6.78
Price to Cash Flow (TTM) -- 23.04 23.45
% Owned Institutions 85.47 0.88 1.40

Dividends

  Company industry sector
Dividend Yield -- 1.56 1.50
Dividend Yield - 5 Year Avg -- 1.57 1.52
Dividend 5 Year Growth Rate -- 4.33 5.17
Payout Ratio(TTM) -- 45.73 43.76

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 3.57 9.00
Sales (TTM) vs TTM 1 Yr. Ago -- 4.66 5.38
Sales - 5 Yr. Growth Rate -- 10.11 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago -49.09 16.54 19.67
EPS (TTM) vs TTM 1 Yr. Ago -44.88 -- --
EPS - 5 Yr. Growth Rate -- 9.86 10.79
Capital Spending - 5 Yr. Growth Rate -- 15.30 15.25

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.11 2.18
Current Ratio (MRQ) 13.45 2.88 2.98
LT Debt to Equity (MRQ) 0.00 9.47 11.56
Total Debt to Equity (MRQ) 0.00 13.43 15.81
Interest Coverage (TTM) -- 36.29 33.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.14 54.83
Gross Margin - 5 Yr. Avg. -- 52.29 52.40
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 18.46 15.24
Operating Margin (TTM) -- 14.50 7.76
Operating Margin - 5 Yr. Avg. -- 14.42 10.75
Pre-Tax Margin (TTM) -- 14.95 8.57
Pre-Tax Margin - 5 Yr. Avg. -- 14.74 11.17
Net Profit Margin (TTM) -- 11.22 4.88
Net Profit Margin - 5 Yr. Avg. -- 11.08 7.47
Effective Tax Rate (TTM) -- 23.21 23.11
Effective Tax Rate - 5 Yr. Avg. -- 23.44 24.00

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 953,213,833 864,673,366
Net Income/Employee (TTM) -1,529,406 112,151,384 101,717,513
Receivable Turnover (TTM) -- 5.60 5.76
Inventory Turnover (TTM) -- 2.58 3.34
Asset Turnover (TTM) 0.00 0.95 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -47.75 11.42 11.00
Return on Assets - 5 Yr. Avg. -- 13.00 12.43
Return on Investment (TTM) -50.47 14.86 14.46
Return on Investment - 5 Yr. Avg. -- 17.00 16.28
Return on Equity (TTM) -50.82 16.28 16.05
Return on Equity - 5 Yr. Avg. -- 18.03 17.51
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -0.51 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Aimmune Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 9.22 5.45 80 25
13 Week 22.10 16.15 89 37
26 Week 26.67 17.04 88 30
52 Week 53.60 30.19 85 12
YTD 24.01 8.91 75 25
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 85.73%
# of Holders: 146
Total Shares Held: 43,604,553
3 Mo. Net Change: 423,124
# New Positions: 14
# Closed Positions: 8
# Increased Positions: 64
# Reduced Positions: 44
# Net Buyers: 20
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.